Neeraj Agarwal, Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), shared a post on X:
“Out now in Journal of Clinical Oncology and Circulation: Our American Heart Association and American Society of Clinical Oncology joint scientific statement on defining cardiovascular (CV) endpoints in oncology trials. A framework for asking CV safety questions before trials begin.”
Title: Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association
Authors: Ana Barac, Avirup Guha, Thomas R. Fleming, Marc Bonaca, Paaladinesh Thavendiranathan, Anita Deswal, Laleh Amiri-Kordestani, Vishal Bhatnagar, Raul Cordoba, Sara Hurvitz, Alex A. Adjei, Neeraj Agarwal
Read the article here or here.
Other articles about American Heart Association on Oncodaily.
